Outcomes of Self-expandable Metal Stents in Patients With Unresectable Gallbladder Cancer Undergoing Percutaneous Biliary Drainage
© 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved..
Background: Biliary obstruction in gallbladder cancer (GBC) is associated with worse prognosis and needs drainage. In patients with biliary confluence involvement, percutaneous biliary drainage (PBD) is preferred over endoscopic drainage. However, PBD catheters are associated with higher complications compared to endoscopic drainage. PBD with self-expandable metal stents (SEMS) is desirable for palliation. However, the data in patients with unresectable GBC is lacking.
Materials and methods: This retrospective study comprised consecutive patients with proven GBC who underwent PBD-SEMS insertion between January 2021 and December 2022. Technical success, post-procedural complications, clinical success, duration of stent patency, and biliary reinterventions were recorded. Clinical follow-up data was analysed at 30 days and 180 days of SEMS insertion and mortality was recorded.
Results: Of the 416 patients with unresectable GBC, who underwent PBD, 28 (median age, 50 years; 16 females) with PBD-SEMS insertion were included. All SEMS placement procedures were technically successful. There were no immediate/early post-procedural complications/deaths. The procedures were clinically successful in 63.6% of the patients with hyperbilirubinemia (n = 11). Biliary re-interventions were done in 6 (21.4%). The survival rate was 89.3 % (25/28) at 30 days and 50% at 180 days. The median follow-up duration was 80 days (range, 8-438 days).
Conclusion: PBD-SEMS has moderate clinical success and 6-months patency in almost half of the patients with metastatic GBC and must be considered for palliation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Journal of clinical and experimental hepatology - 14(2024), 3 vom: 21. Feb., Seite 101348 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Subramanian, Pavithra [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biliary drainage |
|---|
| Anmerkungen: |
Date Revised 24.02.2024 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.jceh.2024.101348 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368798496 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368798496 | ||
| 003 | DE-627 | ||
| 005 | 20240229150417.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jceh.2024.101348 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1304.xml |
| 035 | |a (DE-627)NLM368798496 | ||
| 035 | |a (NLM)38389867 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Subramanian, Pavithra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcomes of Self-expandable Metal Stents in Patients With Unresectable Gallbladder Cancer Undergoing Percutaneous Biliary Drainage |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Background: Biliary obstruction in gallbladder cancer (GBC) is associated with worse prognosis and needs drainage. In patients with biliary confluence involvement, percutaneous biliary drainage (PBD) is preferred over endoscopic drainage. However, PBD catheters are associated with higher complications compared to endoscopic drainage. PBD with self-expandable metal stents (SEMS) is desirable for palliation. However, the data in patients with unresectable GBC is lacking | ||
| 520 | |a Materials and methods: This retrospective study comprised consecutive patients with proven GBC who underwent PBD-SEMS insertion between January 2021 and December 2022. Technical success, post-procedural complications, clinical success, duration of stent patency, and biliary reinterventions were recorded. Clinical follow-up data was analysed at 30 days and 180 days of SEMS insertion and mortality was recorded | ||
| 520 | |a Results: Of the 416 patients with unresectable GBC, who underwent PBD, 28 (median age, 50 years; 16 females) with PBD-SEMS insertion were included. All SEMS placement procedures were technically successful. There were no immediate/early post-procedural complications/deaths. The procedures were clinically successful in 63.6% of the patients with hyperbilirubinemia (n = 11). Biliary re-interventions were done in 6 (21.4%). The survival rate was 89.3 % (25/28) at 30 days and 50% at 180 days. The median follow-up duration was 80 days (range, 8-438 days) | ||
| 520 | |a Conclusion: PBD-SEMS has moderate clinical success and 6-months patency in almost half of the patients with metastatic GBC and must be considered for palliation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a biliary drainage | |
| 650 | 4 | |a endoscopy | |
| 650 | 4 | |a gallbladder cancer | |
| 650 | 4 | |a stents | |
| 700 | 1 | |a Morya, Mukul |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Pankaj |e verfasserin |4 aut | |
| 700 | 1 | |a Siddiqui, Ruby |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Anupam |e verfasserin |4 aut | |
| 700 | 1 | |a Jearth, Vaneet |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Jimil |e verfasserin |4 aut | |
| 700 | 1 | |a Irrinki, Santosh |e verfasserin |4 aut | |
| 700 | 1 | |a Samanta, Jayanta |e verfasserin |4 aut | |
| 700 | 1 | |a Mandavdhare, Harshal |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Vishal |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Harjeet |e verfasserin |4 aut | |
| 700 | 1 | |a Sinha, Saroj K |e verfasserin |4 aut | |
| 700 | 1 | |a Yadav, Thakur D |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Vikas |e verfasserin |4 aut | |
| 700 | 1 | |a Kaman, Lileswar |e verfasserin |4 aut | |
| 700 | 1 | |a Prakash, Gaurav |e verfasserin |4 aut | |
| 700 | 1 | |a Dutta, Usha |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical and experimental hepatology |d 2011 |g 14(2024), 3 vom: 21. Feb., Seite 101348 |w (DE-627)NLM214404560 |x 0973-6883 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2024 |g number:3 |g day:21 |g month:02 |g pages:101348 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jceh.2024.101348 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2024 |e 3 |b 21 |c 02 |h 101348 | ||